Peter Golikov

Peter is a resourceful, results driven leader with 20+ years of experience in general management, drug development and business development. He has a strong business and technical experience in bio-pharmaceutical environments. Peter has previously helped North American universities in marketing unlicensed technologies, mentoring faculty and emerging life science companies in business planning, IP portfolio management, grant applications, fundraising and general management.

Peter has been a leader at two pharmaceutical companies: Virologix, and EpiCept Corporation and was responsible for hiring/managing R&D staff, raising over $18M in private equity capital. During his tenure at EpiCept, he successfully submitted five IND’s and moved three products into late stage clinical development. Earlier in his career, he was a senior clinical research associate for 12 years and gained experience in Phase I-IV clinical studies in several therapeutic areas including analgesia, cardiovascular, and infectious disease. During this tenure four NDAs and NDA Amendments were approved by the FDA.

• Biopharma: Biomedical Applications, Diagnostics, Drug Delivery, Therapeutics, Vaccines
• Therapeutics: Biomedical Research Tools, Animal Models of Disease, Blood & Lymphatic Disease, Cardiovascular, Immunology, Autoimmune & Inflammation, Infectious Diseases, Oncology, Psychiatry, Radiology, Regenerative Medicine - Tissue Engineering, Respiratory & Pulmonary, Transplantation
• Biomedical Other: Precision Health, Biodefense
• Devices and Instrumentation: Consumer Applications, Biomedical
• Imaging: Software, Systems, Tracers/Probes/Reporters
• Software Applications: Life Sciences and Biomedical